Literature DB >> 10228514

End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients.

G D Dodd1, R L Baron, J H Oliver, M P Federle.   

Abstract

PURPOSE: To determine if there is a significant difference in the hepatic morphology depicted on computed tomographic (CT) scans in patients with end-stage cirrhosis caused by primary sclerosing cholangitis versus that in patients with end-stage cirrhosis caused by other factors.
MATERIALS AND METHODS: The frequency of five morphologic findings of the liver parenchyma and two intrahepatic biliary findings identified on CT scans in 36 patients with end-stage cirrhosis caused by primary sclerosing cholangitis were compared with the frequency of the same findings in 472 patients with end-stage cirrhosis caused by other factors. The morphologic findings were lobulation of the liver contour, atrophy of the lateral or posterior hepatic segments, hypertrophy of the caudate lobe, and pseudotumor of the caudate lobe. Lobulation, atrophy, and hypertrophy were subclassified as mild-moderate or severe. The biliary findings were ductal dilatation and calculi.
RESULTS: Each of the 11 findings occurred more frequently (P < .05) in patients with primary sclerosing cholangitis than in the other 472 patients. Six findings occurred more frequently (P < .05) in patients with primary sclerosing cholangitis than in patients with cirrhosis caused by any other single agent.
CONCLUSION: There is a significant difference in the hepatic morphology observed in patients with primary sclerosing cholangitis-induced end-stage cirrhosis versus that in patients with end-stage cirrhosis of other causes.

Entities:  

Mesh:

Year:  1999        PMID: 10228514     DOI: 10.1148/radiology.211.2.r99ma49357

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Segmental hypertrophy mimicking liver tumor in a patient with primary sclerosing cholangitis.

Authors:  Michael Oster; Saif Abu-Mouch; Alicia Nachtigal; Ahmad Mahamid; Abdel-Rauf Zeina
Journal:  J Gastrointest Cancer       Date:  2015-03

2.  Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

Authors:  Massimo Galia; Adele Taibbi; Daniele Marin; Alessandro Furlan; Marco Dioguardi Burgio; Francesco Agnello; Giuseppe Cabibbo; Bernard E Van Beers; Tommaso Vincenzo Bartolotta; Massimo Midiri; Roberto Lagalla; Giuseppe Brancatelli
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

3.  Assessment of Three-Phasic CT Scan Findings of Cirrhosis Due to Primary Sclerosing Cholangitis Versus Cryptogenic Cirrhosis.

Authors:  Nazanin Sadraei; Hamed Jafari; Amin Sadraee; Banafsheh Zeinali-Rafsanjani; Hemmatollah Rastgooyan; Aryan Zahergivar
Journal:  Cureus       Date:  2022-04-08

4.  Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease.

Authors:  Tim O Hirche; Jan Russler; Barbara Braden; Gudrun Schuessler; Stefan Zeuzem; Till Wehrmann; Hans Seifert; Christoph F Dietrich
Journal:  Int J Colorectal Dis       Date:  2004-04-15       Impact factor: 2.571

5.  Altered liver morphology after portal vein thrombosis: not always cirrhosis.

Authors:  Mitchell E Tublin; Alexander J Towbin; Michael P Federle; Michael A Nalesnik
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

Review 6.  Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics.

Authors:  Kumi Ozaki; Kazuto Kozaka; Yasuo Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-28       Impact factor: 2.374

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.